MEG/MRS Dose Response Study of STX209 in ASD
Project Description:
The major goal of this project is to assess the electrophysiologic activity, and begin to develop stratifying variables as predictors of change, of a short-term course of Arbaclofen (STX209) for children with ASD.
Core Function(s):
Performing Direct and/or Demonstration Services, Performing Research or Evaluation
Area of Emphasis
Child Care-Related Activities, Health-Related Activities
Target Audience:
Professionals and Para-Professionals, Family Members/Caregivers
Unserved or Under-served Populations:
Racial or Ethnic Minorities, Disadvantaged Circumstances, Limited English, Geographic Areas, Empowerment Zone, Renewal Community, Reservation, Rural/Remote, Urban, Territory
Primary Target Audience Geographic Descriptor:
National
COVID-19 Related Data:
N/A